Plant Advanced Technologies SA ( ALPAT.PA) Stock. Should you Buy or Sell? $ 16.95
0.10 (0.59 %)
Plant Advanced Technologies SA Analysis
Updated on 03-07-2022
|52 Week Range
||$15.05 - $22.2
Plant Advanced Technologies SA opened the day at $16.95 which is +'0.59 % on yesterday's close.
Plant Advanced Technologies SA has a 52 week high of $22.2 and 52 week low of $15.05, which is a difference of $7.15.
We like to see positive, upward trending shares, preferably with momentum.
Market capitalization is $18.39 M and total net profit is $1537985 which means the company is trading at 11.96 times profit to market capitalization. Theoretically, if you were to buy Plant Advanced Technologies SA for $18.39 M, it would take 15 years to get your money back. Plant Advanced Technologies SA are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.
1 D | All
Plant Advanced Technologies SA Stock Forecast - Is Plant Advanced Technologies SA a Buy or Sell?
|DCF Score||Strong Buy|
|PE Score||Strong Sell|
|PB Score||Strong Buy|
Growth and Value
|Net Profit Margin
Valuing Plant Advanced Technologies SA
|Price Book Value Ratio
||Price To Book Ratio
|Price To Sales Ratio
||Price Earnings Ratio
How liquid is Plant Advanced Technologies SA
||Debt Equity Ratio
|Long Term Debt To Capitalization
||Total Debt To Capitalization
Latest news about Plant Advanced Technologies SA
About Plant Advanced Technologies SA
CEO : Jean-Paul Fevre
Sector : Healthcare
Industry : Biotechnology
Website : https://www.plantadvanced.com
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include PAT Plant Milking that produces active extracts through plant stimulation and living-root exudation while preserving plants; PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes; and PAT Friday, a recombinant protein expression system using natural protein excretion system of genetically modified carnivorous plants to produce outside their leaf in a sterile closed pitcher. The company was founded in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.